2Bleiberg H. Oxaliplatin(L- OHP) :a new reality in colorectal cancer[J]. Br J Cancer, 1998,77(4) : 1 - 3.
3The Meta- analysis Group in Cancer. Efficacy of continuous infusion of fiuorouraeil compared with bolus administration in advanced colorectaI cancer[J]. J Clin Oncol, 1998, 16:301 - 308.
二级参考文献8
1de Gramont A, Vignoud J, Tournigand C, et al. Oxaliplatin with high dose leucovorin and 5-fluorouracil 48 hour continuous infusion in pretreated metastatic colorectal cancer [J]. Eur J Concer,1997, 33(2): 214-219.
2Maindrnult G F, de Gramont A, Louvet C, et al. Evaluation of oxalipltin dose intensity in bimonthly leucovorin and 48 hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreat edmetastaticcolorectal cancet[J]. Oncology Multidisciplinary Resear
3Andre T, Bensmaine M A, Louvet C, et al. Multicenter, phase Ⅱ study of bimonthly high-dose leucovorin, fluorouracil infudion,and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen[J]. Clin Oncol, 1999,
4Sobrero A F, Aschele C, Bertino J R. Fluorouracil in colorectal cancer: A tale of two druga.Implications for biochemical modulation[J].J Clin Oncol, 1997, 15(1): 368-381.
5Machover D. Treatment of advanced colorectal and gastric adenocarinomas with 5-Fluorouracil and high-dose folinicacid [J]. Clin Onco1,1986,4(4):685.
6Raymond E, Faivre S, Woynarowski J M, et al. Oxaliplatin: mechanism of action and antineoplastic activity[J]. Semin Oncol, 1998, 25(2:Suppl 5):4-12.
1Liu Y,He G,Wang Y,et al. MCM-2 is a therapeutic target of Trichosta- tin A in colon ca cells[ J]. Toxicol Lett,2013,221 ( 1 ) :23-30.
2Guzifiska-Ustymowicz K, Pryczynicz A, Kemona A, et al. Correlation be- tween proliferation markers : PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer [ J ]. Anticancer Res, 2009,29 ( 8 ) : 3049-3052.
3Liu Y, He G, Wang Y, et al. MCM-2 is a therapeutic target of Trichosta- tin A in colon cancer cells[ Jl. Toxicol Lett,2013,221 (1) :23-30.
4Giaginis C, Georgiadou M, Dimakopoulou K, et al. Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clin- icopathological parameters and tumor proliferative capacity [ J ]. Dig Dis Sci ,2009,54 (2) :282-291.
5Kwon H J, Hong YK, Park C, et al. Widdrol induces cell cycle arrest, as- sociated withMCM down-regulation, in human colon adenocarcinoma cells[ J]. Cancer Lett,2010,290( 1 ) :96-103.
6Schmidt T, Strowitzki M J, Reissfelder CA, et al. Influence of age on re- section of colorectal liver metastases[ J]. J Surg Oncol, 2015,111 (6) : 729-739.
